BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23284758)

  • 1. Integrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancer.
    Liu Y; Luo X; Hu H; Wang R; Sun Y; Zeng R; Chen H
    PLoS One; 2012; 7(12):e51748. PubMed ID: 23284758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shotgun and Targeted Plasma Proteomics to Predict Prognosis of Non-Small Cell Lung Cancer.
    Li QR; Liu YS; Zeng R
    Methods Mol Biol; 2017; 1619():385-394. PubMed ID: 28674898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins.
    Jin Y; Wang J; Ye X; Su Y; Yu G; Yang Q; Liu W; Yu W; Cai J; Chen X; Liang Y; Chen Y; Wong BH; Fu X; Sun H
    Br J Cancer; 2016 Mar; 114(5):532-44. PubMed ID: 26908325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer.
    Ostroff RM; Bigbee WL; Franklin W; Gold L; Mehan M; Miller YE; Pass HI; Rom WN; Siegfried JM; Stewart A; Walker JJ; Weissfeld JL; Williams S; Zichi D; Brody EN
    PLoS One; 2010 Dec; 5(12):e15003. PubMed ID: 21170350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients.
    Tian M; Cui YZ; Song GH; Zong MJ; Zhou XY; Chen Y; Han JX
    BMC Cancer; 2008 Aug; 8():241. PubMed ID: 18706098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative proteomic analysis of non-small-cell lung cancer and normal controls using serum label-free quantitative shotgun technology.
    Pan J; Chen HQ; Sun YH; Zhang JH; Luo XY
    Lung; 2008; 186(4):255-261. PubMed ID: 18465169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of leucine-rich alpha-2-glycoprotein 1 containing immunocomplexes in the plasma of lung cancer patients with epitope-specific mAbs.
    Lázár J; Kovács A; Tornyi I; Takács L; Kurucz I
    Cancer Biomark; 2022; 34(1):113-122. PubMed ID: 34744074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic identification of exosomal LRG1: a potential urinary biomarker for detecting NSCLC.
    Li Y; Zhang Y; Qiu F; Qiu Z
    Electrophoresis; 2011 Aug; 32(15):1976-83. PubMed ID: 21557262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of reverse phase protein array (RPPA)-based pathway-activation profiling in 84 non-small cell lung cancer (NSCLC) cell lines as platform for cancer proteomics and biomarker discovery.
    Ummanni R; Mannsperger HA; Sonntag J; Oswald M; Sharma AK; König R; Korf U
    Biochim Biophys Acta; 2014 May; 1844(5):950-9. PubMed ID: 24361481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTRF/cavin-1 and MIF proteins are identified as non-small cell lung cancer biomarkers by label-free proteomics.
    Gámez-Pozo A; Sánchez-Navarro I; Calvo E; Agulló-Ortuño MT; López-Vacas R; Díaz E; Camafeita E; Nistal M; Madero R; Espinosa E; López JA; Fresno Vara JÁ
    PLoS One; 2012; 7(3):e33752. PubMed ID: 22461895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-depth proteomic analysis of nonsmall cell lung cancer to discover molecular targets and candidate biomarkers.
    Kikuchi T; Hassanein M; Amann JM; Liu Q; Slebos RJ; Rahman SM; Kaufman JM; Zhang X; Hoeksema MD; Harris BK; Li M; Shyr Y; Gonzalez AL; Zimmerman LJ; Liebler DC; Massion PP; Carbone DP
    Mol Cell Proteomics; 2012 Oct; 11(10):916-32. PubMed ID: 22761400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.
    Hu R; Huffman KE; Chu M; Zhang Y; Minna JD; Yu Y
    J Proteome Res; 2016 Feb; 15(2):477-86. PubMed ID: 26736068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer serum biomarker discovery using label-free liquid chromatography-tandem mass spectrometry.
    Zeng X; Hood BL; Zhao T; Conrads TP; Sun M; Gopalakrishnan V; Grover H; Day RS; Weissfeld JL; Wilson DO; Siegfried JM; Bigbee WL
    J Thorac Oncol; 2011 Apr; 6(4):725-34. PubMed ID: 21304412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic biomarkers of non-small cell lung cancer patients.
    Baran K; Brzeziańska-Lasota E
    Adv Respir Med; 2021; 89(4):419-426. PubMed ID: 34494245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proteomics-based identification of proapoptotic caspase adapter protein as a novel serum marker of non-small cell lung cancer].
    Zhang H; Chen S; Huang L
    Zhongguo Fei Ai Za Zhi; 2012 May; 15(5):287-93. PubMed ID: 22613335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry.
    Zeng X; Hood BL; Sun M; Conrads TP; Day RS; Weissfeld JL; Siegfried JM; Bigbee WL
    J Proteome Res; 2010 Dec; 9(12):6440-9. PubMed ID: 20931982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-depth proteomic analysis of six types of exudative pleural effusions for nonsmall cell lung cancer biomarker discovery.
    Liu PJ; Chen CD; Wang CL; Wu YC; Hsu CW; Lee CW; Huang LH; Yu JS; Chang YS; Wu CC; Yu CJ
    Mol Cell Proteomics; 2015 Apr; 14(4):917-32. PubMed ID: 25638566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoproteomics approach for identifying Glycobiomarker candidate molecules for tissue type classification of non-small cell lung carcinoma.
    Hirao Y; Matsuzaki H; Iwaki J; Kuno A; Kaji H; Ohkura T; Togayachi A; Abe M; Nomura M; Noguchi M; Ikehara Y; Narimatsu H
    J Proteome Res; 2014 Nov; 13(11):4705-16. PubMed ID: 25244057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer.
    Niu L; Song X; Wang N; Xue L; Song X; Xie L
    Cancer Sci; 2019 Jan; 110(1):433-442. PubMed ID: 30407700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis.
    Tan F; Jiang Y; Sun N; Chen Z; Lv Y; Shao K; Li N; Qiu B; Gao Y; Li B; Tan X; Zhou F; Wang Z; Ding D; Wang J; Sun J; Hang J; Shi S; Feng X; He F; He J
    Mol Cell Proteomics; 2012 Feb; 11(2):M111.008821. PubMed ID: 22064513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.